2013 Q1 YTD 2012 Y 2011 Y 2010 Y 2009 Y Source Document 3/31/2013 12/31/2012 12/31/2012 12/31/2012 12/31/2011 Currency Code USD USD USD USD USD (in thousands) Net income 20,044 58,224 44,546 37,356 53,863 Adjustments to reconcile net income to net cash provided by operating activities Provision for loan losses 500 40,750 58,151 66,900 45,300 Net (gain) loss on disposal of property and equipment (20) (424) 28 672 306 Depreciation and amortization 4,203 17,112 17,368 20,136 22,286 Net premium amortization on investment securities 4,082 11,700 10,353 6,762 1,293 Net gains on investment securities transactions (8) (348) (1,544) (170) (137) Net gains on sales of mortgage loans held for sale (7,898) (29,606) (14,443) (15,321) (18,315) Net gain on sales of student loan portfolio
NA
0 0 (374) 0 Net gain on sale of OREO (820) (1,041) (552) (708)
NA
Write-down of OREO
NA
6,724 7,464 6,724 5,545 Write-down of equipment pending disposal
NA
NA
NA
NA
350 Loss on early extinguishment of debt
NA
428 0 306 0 OREO valuation adjustments 2,305
NA
NA
NA
NA
Net reversal of impairment of mortgage servicing rights (48) (771) 1,275 (787) (7,224) Net gain on sale of mortgage servicing rights 0 (19) 0 1,525 48 Deferred income tax expense (benefit) 1,853 8,762 2,405 (17,257) 5,547 Net increase in cash surrender value of company-owned life insurance policies (429) (1,849) (1,824) (1,682) (1,859) Stock-based compensation expense 695 2,485 2,111 1,764 1,067 Tax benefits from stock-based compensation expense 202 360 204 239 742 Excess tax benefits from stock-based compensation (165) (273) (124) (225) (719) Originations of mortgage loans held for sale, net of sales 17,753 12,122 4,466 1,121 19,280 Changes in operating assets and liabilities Decrease (increase) in interest receivable (506) 3,105 1,654 3,495 1,571 Decrease (increase) in other assets (64) 4,089 13,039 8,158 (36,120) Increase (decrease) in accrued interest payable (69) (1,621) (5,055) (4,407) (2,946) Increase (decrease) in accounts payable and accrued expenses (1,861) 5,913 3,579 (4,969) (8,043) Net cash provided by operating activities 39,749 135,822 143,101 109,258 81,835 Purchases of investment securities Held-to-maturity (6,347) (68,305) (18,846) (33,118) (9,910) Available-for-sale (227,040) (1,246,068) (1,166,364) (1,317,938) (868,917) Proceeds from maturities and pay-downs of investment securities Held-to-maturity 3,512 12,192 12,682 15,134 19,785 Available-for-sale 201,621 1,252,266 943,490 833,910 493,389 Proceeds from sales of mortgage servicing rights 311 907 596 2,480 2,051 Extensions of credit to customers, net of repayments (22,997) (128,919) 90,548 71,762 146,943 Proceeds from sale of student loan portfolio
NA
0 0 25,032 0 Recoveries of loans charged-off 2,913 8,116 5,231 2,889 2,392 Proceeds from sales of OREO 3,957 42,814 15,896 20,336 10,849 Capital contribution to equity method investment
NA
(900) 0 0
NA
Capital distribution from unconsolidated subsidiary
NA
1,238 0 0
NA
Capital expenditures, net of sales (650) (14,420) (9,172) (7,998) (26,393) Net cash provided by (used in) investing activities (44,720) (141,079) (125,939) (387,511) (229,811) Net increase (decrease) in deposits (212,066) 413,440 (98,742) 101,657 649,797 Net decrease in federal funds purchased
NA
NA
NA
NA
(30,625) Net decrease in repurchase agreements (38,580) (10,458) (103,911) 146,013 (51,360) Net decrease in short-term borrowings (24) 25 (4,984) (432) (73,793) Repayments of long-term debt (10) (40) (302) (35,851) (10,795) Debt issuance costs
NA
NA
NA
NA
(261) Repayment of junior subordinated debentures held by subsidiary trusts
NA
(41,238) 0 0
NA
Redemption of preferred stock (50,000)
NA
NA
NA
NA
Proceeds from issuance of common stock 3,145 1,911 385 167,400 3,914 Common stock issuance costs
NA
0 0 (13,597) 0 Excess tax benefits from stock-based compensation 165 273 124 225 719 Purchase and retirement of common stock (448) (263) (248) (3,699) (11,052) Dividends paid to common stockholders 0 (26,208) (19,233) (17,905) (15,694) Dividends paid to preferred stockholders 0 (3,300) (3,422) (3,422) (3,422) Net cash provided by (used in) financing activities (297,818) 334,142 (230,333) 340,389 457,428 Net increase (decrease) in cash and cash equivalents (302,789) 328,885 (213,171) 62,136 309,452 Cash and cash equivalents at beginning of period 801,332 472,447 685,618 623,482 314,030 Cash and cash equivalents at end of period 498,543 801,332 472,447 685,618 623,482 Cash paid during the period for income taxes 3,376 17,540 16,640 37,325 25,813 Cash paid during the period for interest expense 5,859 31,735 47,086 67,514 87,844
Data shown on this page is extracted directly from the company's documents. SNL makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company's presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, SNL, as always, stands by its commitment to the quality of the data.
